In The Know-September 2022

September 2022

Pdf Summary

This document summarizes significant studies in gynecologic oncology, including genetic testing in ovarian cancer, intraoperative imaging, gene mutations, endometrial cancer detection, targeting kinase cascade, HPV vaccination impact, PCOS and pancreatic cancer, surgical response during COVID-19, PARP inhibitors in ovarian cancer, and the association between PCOS and pancreatic cancer. Overall, these studies contribute to understanding and improving treatment strategies and patient outcomes in gynecologic oncology. The studies cover a range of topics such as long-term survival with olaparib, sentinel lymph node biopsy in melanoma, BRCA1 promoter methylation and cancer risk, PARP inhibitors in ovarian cancer, FAM19A4/miR124-2 methylation as a prognostic marker, and the importance of HPV testing and methylation triage in cervical cancer elimination.

Keywords

genetic testing

ovarian cancer

intraoperative imaging

gene mutations

endometrial cancer detection

targeting kinase cascade

HPV vaccination impact

PCOS

pancreatic cancer

surgical response